Aura 2016 Supplementary data


Table S4.32 Methicillin-resistant Staphylococcus aureus resistance, by specimen source, 2014



Yüklə 388,53 Kb.
səhifə24/26
tarix12.02.2017
ölçüsü388,53 Kb.
#8296
1   ...   18   19   20   21   22   23   24   25   26

Table S4.32 Methicillin-resistant Staphylococcus aureus resistance, by specimen source, 2014


Antimicrobial

Blood, % resistance (n)

Other, % resistance (n)

Total, % resistance (n)

Penicillin

100 (634)

100 (5 826)

100.0 (6 460)

Oxacillin

98.1 (635)

99.9 (10 439)

99.8 (11 074)

Ciprofloxacin

42.9 (611)

12.6 (5 813)

15.5 (6 424)

Erythromycin

45.4 (636)

23.7 (10 445)

25.0 (11 081)

Clindamycin

20.6 (637)

19.0 (10 547)

19.1 (11 184)

Trimethoprim–sulfamethoxazole

11.8 (636)

5.2 (10 530)

5.5 (11 166)

Gentamicin

15.0 (612)

4.1 (5 818)

5.1 (6 430)

Rifampicin

0.8 (628)

0.9 (10 333)

0.9 (10 961)

Fusidic acid

4.6 (633)

5.9 (10 462)

5.8 (11 095)

Linezolid

0.3 (600)

0.1 (9 557)

0.1 (10 157)

Daptomycin

1.0 (599)

0.6 (9 587)

0.6 (10 186)

Tetracycline

15.8 (631)

7.2 (10 062)

7.7 (10 693)

Nitrofurantoin

0.0 (409)

na

0.0 (409)

Vancomycin

0.0 (643)

0.0 (10 477)

0.0 (11 120)

na = not available (either not tested or tested against an inadequate number of isolates)

Sources: AGAR (public and private hospitals); OrgTRx, Queensland (public hospitals and health services); SNP (private hospitals, community and residential aged care facilities)


Table S4.33 Methicillin-resistant Staphylococcus aureus resistance, by clinical setting, 2014


Antimicrobial

Public hospitals, % resistance (n)

Public hospitals and health services, % resistance (n)

Private hospitals, % resistance (n)

Community, % resistance (n)

Residential aged care facilities, % resistance (n)

Penicillin

100.0 (408)

100.0 (6023)

100.0 (28)

na

na

Oxacillin

97.3 (409)

100.0 (6024)

99.3 (534)

99.9 (3591)

99.6 (516)

Ciprofloxacin

51.6 (409)

13.0 (6008)

na

na

na

Erythromycin

49.1 (409)

20.6 (6029)

46.2 (535)

24.1 (3592)

41.3 (516)

Clindamycin

16.4 (409)

14.6 (6135)

41.5 (533)

20.8 (3591)

39.3 (516)

Trimethoprim–sulfamethoxazole

12.7 (408)

5.3 (6116)

10.5 (535)

4.5 (3591)

5.2 (516)

Gentamicin

18.1 (409)

4.2 (6014)

na

na

na

Rifampicin

1.2 (407)

0.7 (6017)

1.6 (514)

1.0 (3484)

1.3 (539)

Fusidic acid

4.2 (409)

4.6 (6015)

9.6 (551)

6.7 (3571)

11.1 (549)

Linezolid

0.5 (409)

0.1 (5391)

0.0 (461)

0.1 (3425)

0.2 (471)

Daptomycin

1.5 (407)

0.5 (5422)

0.7 (461

0.7 (3425)

0.8 (471)

Tetracycline

19.1 (409)

6.4 (5991)

13.0 (530)

7.1 (3249)

11.1 (514)

Nitrofurantoin

0.0 (406)

na

na

na

na

Vancomycin

0.0 (409)

0.0 (6014)

0.0 (555)

0.1 (3589)

0.2 (553)

na = not available (either not tested or tested against an inadequate number of isolates)

Sources: AGAR (public and private hospitals); OrgTRx, Queensland (public hospitals and health services); SNP (private hospitals, community and residential aged care facilities)




Yüklə 388,53 Kb.

Dostları ilə paylaş:
1   ...   18   19   20   21   22   23   24   25   26




Verilənlər bazası müəlliflik hüququ ilə müdafiə olunur ©azkurs.org 2024
rəhbərliyinə müraciət

gir | qeydiyyatdan keç
    Ana səhifə


yükləyin